NCT04316520View on ClinicalTrials.gov

Ketogenic Diet for Patients Receiving Treatment for Metastatic Renal Cell Carcinoma

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 22, 2020

Primary Completion Date

January 6, 2023

Study Completion Date

March 6, 2024

Conditions
Metastatic Renal Cancer
Interventions
DIETARY_SUPPLEMENT

Ketogenic diet

Ketogenic diet 2:1

Trial Locations (1)

Unknown

CHU Angers, Angers

All Listed Sponsors
collaborator

Vitaflo International, Ltd

INDUSTRY

lead

University Hospital, Angers

OTHER_GOV

NCT04316520 - Ketogenic Diet for Patients Receiving Treatment for Metastatic Renal Cell Carcinoma | Biotech Hunter | Biotech Hunter